European Bifurcation Club Trial - Two-stent Versus One-stent Technique for Large Bifurcation Lesions

Last updated: March 11, 2016
Sponsor: Royal Sussex County Hospital
Overall Status: Completed

Phase

3

Condition

Coronary Artery Disease

Chest Pain

Thrombosis

Treatment

N/A

Clinical Study ID

NCT01560455
EBC TWO
  • Ages > 18
  • All Genders

Study Summary

This study will examine use of two-stent versus one-stent techniques for patients with large calibre bifurcation lesions including significant side branch disease.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • "True" coronary bifurcation lesion (i.e. >50% lesion in both main vessel and sidebranch) requiring revascularisation

  • Main vessel ≥ 2.5mm diameter (visual inspection)

  • Side branch ≥ 2.5mm diameter (visual inspection)

  • Side branch ostial lesion ≥5mm length

  • Patient ≥18 years old

  • Females of childbearing potential: -ve pregnancy test

Exclusion

Exclusion Criteria:

  • Acute ST elevation myocardial infarction

  • Cardiogenic shock

  • Left main stem lesion of haemodynamic significance

  • Chronic total occlusion of either vessel

  • Additional Type C lesions requiring PCI

  • Either bifurcation vessel not suitable for stenting

  • Platelet count ≤50 x 109/mm3

  • Left ventricular ejection fraction ≤20%

  • Patient life expectancy less than 12 months

  • Known allergies to aspirin, clopidogrel, heparin, stainless steel, intravenouscontrast (severe), or stent drug elutant

  • Participation in another investigational drug or device study

  • Patient unable to give informed consent

Study Design

Total Participants: 200
Study Start date:
May 01, 2011
Estimated Completion Date:

Study Description

Treatment of bifurcation coronary lesions remains a difficult area, in which best practice is yet to be established. Prior to the era of drug-eluting stents, the limited data which existed suggested that a strategy of stenting the main vessel, with balloon angioplasty alone of the side-branch if required was superior to stenting both vessels.

Randomised trials of "all-comer" bifurcation lesions have now established that there is no advantage to systematic dual drug-eluting stent strategies. However, these trials included patients with no disease in the side branch, and small side branch vessels.

Expert consensus suggests that "large" bifurcations with significant ostial side branch disease still merit a systematic total lesion coverage stent technique. This trial therefore is designed to assess the hypothesis that large true bifurcations with significant side branch ostial disease are more successfully treated with a systematic culotte technique than with the provisional T approach.

Connect with a study center

  • Sussex Cardiac Centre

    Brighton, East Sussex BN2 1DE
    United Kingdom

    Site Not Available

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.